Both in Pharmaceuticals
CytomX Therapeutics vs Climb Bio
Over the past year CTMX returned −42.5% and CLYM returned +396.3%; their daily moves had a correlation of 0.33.
CTMX −42.5% CLYM +396.3%Growth of $1, one year, split-adjusted
| Metric | CTMX | CLYM |
|---|---|---|
| Price | $2.35 | $9.33 |
| Market cap | $512.1M | $535.9M |
| Today | +7.80% | −4.31% |
| 1 month | −8.2% | −12.6% |
| 6 months | −43.1% | −23.6% |
| Year to date | −44.8% | +133.3% |
| 1 year | −40.2% | +366.5% |
| Revenue growth (YoY) | −92.4% | — |
| Gross margin | 100.0% | — |
| Net margin | −1457.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 28.0× | — |
| Net cash | $330.3M | $183.1M |
| Dividend yield | — | — |
| Volatility (60d) | 69.6% | 80.8% |
| Short % of float | 21.4% | 25.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).